Skip to main content
Clinical Trials/EUCTR2011-002104-32-DE
EUCTR2011-002104-32-DE
Active, not recruiting
Not Applicable

A trial investigating the pharmacokinetic properties of FIAsp in children, adolescents and adults with type 1 diabetes

ovo Nordisk A/S0 sitesOctober 10, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 1
Sponsor
ovo Nordisk A/S
Status
Active, not recruiting
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2013
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Male or female aged 6–64 years (both inclusive) at the time of signing informed consent.
  • 2\. Type 1 diabetes mellitus (as diagnosed clinically) \= 12 months.
  • 3\. Body mass index (BMI) for children and adolescents (male and female) between the 3rd and 97th BMI percentile and for adults \= 28\.0 kg/m^2\.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 26
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 13
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. Subject who has donated any blood or plasma in the past month or more than 500 mL within 3 months prior to screening.
  • 2\. Smoker (defined as a subject who is smoking at least one cigarette, cigar or pipe daily).
  • 3\. Not able or willing to refrain from smoking and use of nicotine substitute products during the inpatient period.

Outcomes

Primary Outcomes

Not specified

Similar Trials